MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein*
暂无分享,去创建一个
Yuan Wang | Lihong Ye | Shan Gao | L. Ye | Xiao-dong Zhang | Y. Wang | G. Feng | Zhe Yang | Xiaodong Zhang | Yueguo Li | Zhe Yang | Jiong Li | Guoxing Feng | Shan Gao | Shuqin Zhang | Yunxia Liu | Jiong Li | Yun-xia Liu | Shuqin Zhang | Yueguo Li
[1] N. Dong,et al. The role of miR-145 in microvasculature. , 2013, Die Pharmazie.
[2] O. Elemento,et al. Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons , 2012, Cell.
[3] N. Seki,et al. SWAP70, actin‐binding protein, function as an oncogene targeting tumor‐suppressive miR‐145 in prostate cancer , 2011, The Prostate.
[4] F. Bock,et al. Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer. , 2015, Trends in molecular medicine.
[5] Jie Zheng,et al. Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2 , 2010, Cell Research.
[6] Radhika Das,et al. Role of the N6-methyladenosine RNA mark in gene regulation and its implications on development and disease. , 2015, Briefings in functional genomics.
[7] E. Lai,et al. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. , 2011, Molecular cell.
[8] Yun-Gui Yang,et al. N6-methyl-adenosine (m6A) in RNA: An Old Modification with A Novel Epigenetic Function , 2012, Genom. Proteom. Bioinform..
[9] Yumei Du,et al. Hepatitis B virus X protein protects hepatoma and hepatic cells from complement‐dependent cytotoxicity by up‐regulation of CD46 , 2013, FEBS letters.
[10] M. Hastings. m6A mRNA Methylation: A New Circadian Pacesetter , 2013, Cell.
[11] A. Pasquinelli,et al. MicroRNA biogenesis: regulating the regulators , 2013, Critical reviews in biochemistry and molecular biology.
[12] Jun Yan,et al. MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. , 2012, Biochemical and biophysical research communications.
[13] Arne Klungland,et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.
[14] Yue Zhang,et al. MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma , 2016, Tumor Biology.
[15] G. Rechavi,et al. FTO: linking m6A demethylation to adipogenesis , 2014, Cell Research.
[16] Chuan He,et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis , 2014, Cell Research.
[17] Zhi-mao Jiang,et al. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma , 2014, Journal of Cancer Research and Clinical Oncology.
[18] Y. Zhang,et al. The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.
[19] Chengqi Yi,et al. N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.
[20] Claudio Franceschi,et al. A polymorphism of the YTHDF2 gene (1p35) located in an Alu-rich genomic domain is associated with human longevity. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[21] Samir Adhikari,et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase , 2014, Cell Research.
[22] C. Creighton,et al. Overexpression of miR-145–5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression , 2015, Cancer investigation.
[23] H. Soifer,et al. MicroRNAs in disease and potential therapeutic applications. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] J. Vandesompele,et al. Identification of miR-145 as a key regulator of the pigmentary process. , 2013, The Journal of investigative dermatology.
[25] Shu-Bing Qian,et al. Dynamic m6A mRNA methylation directs translational control of heat shock response , 2015, Nature.
[26] P. Sharp,et al. The role of miRNAs in regulating gene expression networks. , 2013, Journal of molecular biology.
[27] N. Wong,et al. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. , 2012, Carcinogenesis.
[28] Ligang Wu,et al. YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex , 2016, Nature Communications.
[29] E. Olson,et al. A Role for miR-145 in Pulmonary Arterial Hypertension: Evidence From Mouse Models and Patient Samples , 2012, Circulation research.
[30] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[31] Yumei Du,et al. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. , 2011, Carcinogenesis.
[32] Chuan He,et al. N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.
[33] J. Doudna,et al. A three-dimensional view of the molecular machinery of RNA interference , 2009, Nature.
[34] Youliang Wang,et al. Hepatitis B virus X protein modulates oncogene yes‐associated protein by CREB to promote growth of hepatoma cells , 2012, Hepatology.
[35] Shu‐hong Li,et al. Role of miR-145 in cardiac myofibroblast differentiation. , 2014, Journal of molecular and cellular cardiology.
[36] Tao Zhang,et al. Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. , 2013, Carcinogenesis.
[37] Sheng Li,et al. The pivotal regulatory landscape of RNA modifications. , 2014, Annual review of genomics and human genetics.
[38] Chen Hu,et al. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. , 2014, Biochemical and biophysical research communications.
[39] Bing Ren,et al. N6-methyladenosine-dependent regulation of messenger RNA stability , 2013 .
[40] Q. Hao,et al. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. , 2013, Biochemical and biophysical research communications.
[41] Xihong Zhou,et al. FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice , 2015, Journal of Physiology and Biochemistry.
[42] Qun Zhou,et al. lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6 , 2014, Molecular Cancer Research.
[43] Zhike Lu,et al. m6A-dependent regulation of messenger RNA stability , 2013, Nature.
[44] Jian-Jun Wei,et al. miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma , 2014, Oncotarget.
[45] Feng Wang,et al. miR-145 Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma in Part by Targeting c-Myc , 2013, Onkologie.
[46] R. Shiekhattar,et al. MicroRNA biogenesis: isolation and characterization of the microprocessor complex. , 2006, Methods in molecular biology.
[47] Yu Zhao,et al. The Nuclear Import of Oncoprotein Hepatitis B X-interacting Protein Depends on Interacting with c-Fos and Phosphorylation of Both Proteins in Breast Cancer Cells , 2013, The Journal of Biological Chemistry.
[48] Jiejie Xu,et al. EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma , 2015, Nature Communications.
[49] Christopher E. Mason,et al. Novel RNA regulatory mechanisms revealed in the epitranscriptome , 2013, RNA biology.
[50] T. Pan. N6-methyl-adenosine modification in messenger and long non-coding RNA. , 2013, Trends in biochemical sciences.
[51] Yong-hong Gu,et al. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1 , 2015, Digestive Diseases and Sciences.
[52] Thomas Preiss,et al. Mapping and significance of the mRNA methylome , 2013, Wiley interdisciplinary reviews. RNA.